HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David J Panka Selected Research

aldesleukin (Proleukin)

5/2017FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma.
2/2015The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David J Panka Research Topics

Disease

9Neoplasms (Cancer)
06/2021 - 07/2010
8Melanoma (Melanoma, Malignant)
06/2021 - 02/2006
6Renal Cell Carcinoma (Grawitz Tumor)
07/2019 - 07/2010
2Necrosis
06/2021 - 09/2011
1Anaplastic Thyroid Carcinoma
01/2018
1Thyroid Neoplasms (Thyroid Cancer)
01/2018
1Disease Progression
08/2016
1Craniopharyngioma (Craniopharyngiomas)
02/2016
1Hypoxia (Hypoxemia)
07/2010

Drug/Important Bio-Agent (IBA)

5Sorafenib (BAY 43-9006)FDA Link
06/2021 - 02/2006
3CaspasesIBA
10/2019 - 02/2006
3Interleukin-2 (IL2)IBA
05/2017 - 05/2008
2Sunitinib (Sutent)FDA Link
06/2021 - 03/2013
2Sirolimus (Rapamycin)FDA Link
07/2019 - 07/2010
2dactolisibIBA
07/2019 - 07/2010
2Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
07/2019 - 07/2010
2RNA (Ribonucleic Acid)IBA
01/2018 - 01/2016
2AntibodiesIBA
01/2018 - 05/2017
2VaccinesIBA
05/2017 - 05/2008
2aldesleukin (Proleukin)FDA Link
05/2017 - 02/2015
2dabrafenibIBA
08/2016 - 02/2016
2trametinibIBA
08/2016 - 02/2016
2Phosphotransferases (Kinase)IBA
09/2011 - 04/2006
2Pharmaceutical PreparationsIBA
09/2011 - 04/2006
2Mitogen-Activated Protein KinasesIBA
04/2006 - 02/2006
1ThyroglobulinFDA Link
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Neoplasm Antigens (Tumor Antigens)IBA
05/2017
1IgG Receptors (Fc gamma RI)IBA
05/2017
1Glutamine (L-Glutamine)FDA Link
01/2016
1B7-H1 AntigenIBA
02/2015
1Messenger RNA (mRNA)IBA
01/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2013
1Small Interfering RNA (siRNA)IBA
09/2011
1MI 319IBA
09/2011
1Mechanistic Target of Rapamycin Complex 1IBA
07/2010
1Cyclin D1IBA
07/2010
1Eukaryotic Initiation Factor-4EIBA
07/2010
1Peptides (Polypeptides)IBA
05/2008
1CytokinesIBA
05/2008
1Glycogen Synthase Kinase 3 betaIBA
01/2008
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
04/2006
1GTP Phosphohydrolases (GTPases)IBA
04/2006
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2006
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
04/2006

Therapy/Procedure

5Therapeutics
01/2018 - 03/2013
1Thyroidectomy
01/2018
1Immunotherapy
05/2017
1Nephrectomy
02/2015